Jason Meggs's Insider Trades & SAST Disclosures
Jason Meggs's most recent trade in Syneos Health Inc - Ordinary Shares - Class A was a trade of 5,383 Class A Common Stock done . Disclosure was reported to the exchange on Feb. 23, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jason Meggs.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 5,383 | 71,444 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.25 per share. | 23 Feb 2023 | 2,607 | 71,112 (0%) | 0% | 38.3 | 99,718 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 1,401 | 72,845 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 874 | 73,719 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.76 per share. | 17 Jan 2023 | 2,842 | 66,927 (0%) | 0% | 34.8 | 98,788 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.80 per share. | 17 Jan 2023 | 866 | 66,061 (0%) | 0% | 34.8 | 30,137 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 15,033 | 69,769 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 72.81 per share. | 18 Jul 2022 | 7,500 | 54,736 (0%) | 0% | 72.8 | 546,075 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 9,364 | 63,853 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.75 per share. | 02 Mar 2022 | 6,453 | 62,236 (0%) | 0% | 80.8 | 521,080 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 2,513 | 68,689 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 2,323 | 66,176 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 8,890 | 54,489 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.09 per share. | 18 Jan 2022 | 3,179 | 45,599 (0%) | 0% | 86.1 | 273,680 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.69 per share. | 10 Jan 2022 | 1,700 | 48,778 (0%) | 0% | 93.7 | 159,273 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jan 2022 | 1,000 | 50,478 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 03 Sep 2021 | 9,223 | 51,478 (0%) | 0% | 95 | 876,185 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2021 | 620 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 06 Jul 2021 | 620 | 60,701 (0%) | 0% | 90 | 55,800 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.00 per share. | 06 Jul 2021 | 620 | 61,321 (0%) | 0% | 46 | 28,520 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 06 Jul 2021 | 40 | 60,701 (0%) | 0% | 90 | 3,600 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2021 | 40 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.15 per share. | 06 Jul 2021 | 40 | 60,741 (0%) | 0% | 43.2 | 1,726 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2021 | 2,600 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 30 Jun 2021 | 2,600 | 60,701 (0%) | 0% | 90 | 234,000 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.88 per share. | 30 Jun 2021 | 2,600 | 63,301 (0%) | 0% | 42.9 | 111,488 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 30 Jun 2021 | 2,068 | 60,701 (0%) | 0% | 90 | 186,120 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2021 | 2,068 | 40 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.16 per share. | 30 Jun 2021 | 2,068 | 62,769 (0%) | 0% | 43.2 | 89,255 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 84.00 per share. | 15 Apr 2021 | 6,000 | 60,701 (0%) | 0% | 84 | 504,000 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.50 per share. | 02 Mar 2021 | 2,278 | 66,701 (0%) | 0% | 75.5 | 171,989 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 2,038 | 67,759 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 1,220 | 68,979 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.59 per share. | 16 Feb 2021 | 3,475 | 65,721 (0%) | 0% | 78.6 | 273,100 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 13,344 | 69,196 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.42 per share. | 15 Jan 2021 | 1,367 | 55,852 (0%) | 0% | 75.4 | 103,099 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.59 per share. | 08 Jan 2021 | 1,732 | 57,219 (0%) | 0% | 73.6 | 127,458 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 72.00 per share. | 06 Jan 2021 | 5,552 | 58,951 (0%) | 0% | 72 | 399,744 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2021 | 1,500 | 64,503 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 67.00 per share. | 27 Nov 2020 | 4,062 | 66,003 (0%) | 0% | 67 | 272,154 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 67.00 per share. | 24 Nov 2020 | 1,938 | 70,065 (0%) | 0% | 67 | 129,846 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Jason Meggs | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.94 per share. | 01 Nov 2020 | 35 | 72,003 (0%) | 0% | 55.9 | 1,958 | Class A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges